Zobrazeno 1 - 2
of 2
pro vyhledávání: '"inhibiteur des kinases dépendantes des cyclines"'
Publikováno v:
Can J Hosp Pharm
Background: Real-world data are critical to demonstrate the reproducibility of evidence and the external generalizability of randomized clinical trials. Palbociclib is an oral small-molecule inhibitor of cyclin-dependent kinases 4/6 that has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ec21a16ca0c11d1ce68ddf36c1b476
https://www.cjhp-online.ca/index.php/cjhp/article/download/3252/4640
https://www.cjhp-online.ca/index.php/cjhp/article/download/3252/4640
Autor:
Fernández-Cuerva C; MSc, is a Hospital Pharmacy Specialist with the Hospital Regional Universitario de Málaga, Málaga, Spain., Valencia JCDR; PharmD, is a Hospital Pharmacy Specialist with St Bernard's Hospital, Gibraltar., Bermejo RT; PharmD, is a Hospital Pharmacy Specialist with the Hospital Regional Universitario de Málaga, Málaga, Spain.
Publikováno v:
The Canadian journal of hospital pharmacy [Can J Hosp Pharm] 2022 Winter; Vol. 75 (1), pp. 26-33.